LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its attendance at HLTH Europe 2026, one of the healthcare industry's leading conferences focused on innovation and digital health. The company highlighted key industry insights and strategic engagements from the event, which took place in June 2026.
Management stated that attending HLTH Europe allowed LataMed AI to engage directly with healthcare innovators, technology companies, healthcare providers, insurers, and digital health organizations from across Europe, Latin America, and other international markets. The conference also provided an opportunity to increase awareness of the company's developing healthcare technology platform among a broad range of industry participants.
The company noted that the conference reinforced its belief that healthcare systems increasingly require integrated digital solutions capable of improving patient accessibility, care coordination, financial accessibility, and operational efficiency. Management observed growing interest across the healthcare sector in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions.
According to LataMed AI, many of the themes discussed at HLTH Europe align closely with its ongoing efforts to develop an integrated healthcare ecosystem that combines telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions. The company believes engagement with global healthcare stakeholders is an important component of its long-term strategy as it continues to advance the development of its integrated healthcare ecosystem throughout Latin America.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways from the conference was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI. The conference also provided valuable visibility for our platform initiatives and an opportunity to establish new industry relationships that may support our future growth objectives.”
The company is currently reviewing and evaluating various follow-up opportunities resulting from discussions held during the conference and intends to provide additional updates regarding any material developments as appropriate. Photographs and highlights from LataMed AI's attendance at HLTH Europe 2026 are available through the company's official Instagram page, and management intends to continue sharing updates through official communication channels.
For additional information, visit LataMed AI's website or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
